Survey of infants hospitalized for respiratory syncytial virus disease in Tokyo, 2018

Pediatr Int. 2021 Feb;63(2):219-221. doi: 10.1111/ped.14381. Epub 2021 Feb 13.

Authors

Ayako Seimiya¹, Ichiro Morioka¹, Aya Okahashi¹, Nobuhiko Nagano¹, Hitoshi Yoda²

Affiliations

¹ Departments of, Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
² Department of, Neonatology, Toho University School of Medicine, Tokyo, Japan.

PMID: 33580907
DOI: 10.1111/ped.14381

No abstract available

Keywords: epidemic; hospitalization; infants; palivizumab; respiratory syncytial virus.

MeSH terms

Antiviral Agents / therapeutic use
Hospitalization
Humans
Infant
Palivizumab / therapeutic use
Respiratory Syncytial Virus Infections* / diagnosis
Respiratory Syncytial Virus Infections* / drug therapy
Respiratory Syncytial Virus Infections* / epidemiology
Respiratory Syncytial Viruses
Tokyo / epidemiology

Substances

Antiviral Agents
Palivizumab